Literature DB >> 24913711

The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.

Simon J Furney1, Samra Turajlic, Gordon Stamp, J Meirion Thomas, Andrew Hayes, Dirk Strauss, Mike Gavrielides, Wei Xing, Martin Gore, James Larkin, Richard Marais.   

Abstract

Acral melanoma is a subtype of melanoma with distinct epidemiological, clinical and mutational profiles. To define the genomic alterations in acral melanoma, we conducted whole-genome sequencing and SNP array analysis of five metastatic tumours and their matched normal genomes. We identified the somatic mutations, copy number alterations and structural variants in these tumours and combined our data with published studies to identify recurrently mutated genes likely to be the drivers of acral melanomagenesis. We compared and contrasted the genomic landscapes of acral, mucosal, uveal and common cutaneous melanoma to reveal the distinctive mutational characteristics of each subtype.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  acral melanoma; mutational burden; somatic mutations; whole-genome sequencing

Mesh:

Year:  2014        PMID: 24913711     DOI: 10.1111/pcmr.12279

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  46 in total

1.  Melanoma subtypes demonstrate distinct PD-L1 expression profiles.

Authors:  Genevieve J Kaunitz; Tricia R Cottrell; Mohammed Lilo; Valliammai Muthappan; Jessica Esandrio; Sneha Berry; Haiying Xu; Aleksandra Ogurtsova; Robert A Anders; Alexander H Fischer; Stefan Kraft; Meg R Gerstenblith; Cheryl L Thompson; Kord Honda; Jonathan D Cuda; Charles G Eberhart; James T Handa; Evan J Lipson; Janis M Taube
Journal:  Lab Invest       Date:  2017-07-24       Impact factor: 5.662

2.  Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.

Authors:  Robert V Rawson; Peter A Johansson; Nicholas K Hayward; Nicola Waddell; Ann-Marie Patch; Serigne Lo; John V Pearson; John F Thompson; Graham J Mann; Richard A Scolyer; James S Wilmott
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

3.  A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.

Authors:  Clemens Krepler; Katrin Sproesser; Patricia Brafford; Marilda Beqiri; Bradley Garman; Min Xiao; Batool Shannan; Andrea Watters; Michela Perego; Gao Zhang; Adina Vultur; Xiangfan Yin; Qin Liu; Ioannis N Anastopoulos; Bradley Wubbenhorst; Melissa A Wilson; Wei Xu; Giorgos Karakousis; Michael Feldman; Xiaowei Xu; Ravi Amaravadi; Tara C Gangadhar; David E Elder; Lauren E Haydu; Jennifer A Wargo; Michael A Davies; Yiling Lu; Gordon B Mills; Dennie T Frederick; Michal Barzily-Rokni; Keith T Flaherty; Dave S Hoon; Michael Guarino; Joseph J Bennett; Randall W Ryan; Nicholas J Petrelli; Carol L Shields; Mizue Terai; Takami Sato; Andrew E Aplin; Alexander Roesch; David Darr; Steve Angus; Rakesh Kumar; Ensar Halilovic; Giordano Caponigro; Sebastien Jeay; Jens Wuerthner; Annette Walter; Matthias Ocker; Matthew B Boxer; Lynn Schuchter; Katherine L Nathanson; Meenhard Herlyn
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

Review 4.  Emerging strategies to treat rare and intractable subtypes of melanoma.

Authors:  Gretchen M Alicea; Vito W Rebecca
Journal:  Pigment Cell Melanoma Res       Date:  2020-04-24       Impact factor: 4.693

Review 5.  Is UV an etiological factor of acral melanoma?

Authors:  Lin Liu; Weigang Zhang; Tianwen Gao; Chunying Li
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-10-14       Impact factor: 5.563

6.  Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review.

Authors:  Douglas B Johnson; Chengwei Peng; Richard G Abramson; Fei Ye; Shilin Zhao; Jedd D Wolchok; Jeffrey A Sosman; Richard D Carvajal; Charlotte E Ariyan
Journal:  Oncologist       Date:  2015-05-11

7.  The efficacy of anti-PD-1 agents in acral and mucosal melanoma.

Authors:  Alexander N Shoushtari; Rodrigo R Munhoz; Deborah Kuk; Patrick A Ott; Douglas B Johnson; Katy K Tsai; Suthee Rapisuwon; Zeynep Eroglu; Ryan J Sullivan; Jason J Luke; Tara C Gangadhar; April K S Salama; Varina Clark; Clare Burias; Igor Puzanov; Michael B Atkins; Alain P Algazi; Antoni Ribas; Jedd D Wolchok; Michael A Postow
Journal:  Cancer       Date:  2016-08-17       Impact factor: 6.860

Review 8.  Translational pathology, genomics and the development of systemic therapies for acral melanoma.

Authors:  Yian Ann Chen; Jamie K Teer; Zeynep Eroglu; Jheng-Yu Wu; John M Koomen; Florian A Karreth; Jane L Messina; Keiran S M Smalley
Journal:  Semin Cancer Biol       Date:  2019-11-02       Impact factor: 15.707

9.  Whole-genome landscapes of major melanoma subtypes.

Authors:  Nicholas K Hayward; James S Wilmott; Nicola Waddell; Peter A Johansson; Matthew A Field; Katia Nones; Ann-Marie Patch; Hojabr Kakavand; Ludmil B Alexandrov; Hazel Burke; Valerie Jakrot; Stephen Kazakoff; Oliver Holmes; Conrad Leonard; Radhakrishnan Sabarinathan; Loris Mularoni; Scott Wood; Qinying Xu; Nick Waddell; Varsha Tembe; Gulietta M Pupo; Ricardo De Paoli-Iseppi; Ricardo E Vilain; Ping Shang; Loretta M S Lau; Rebecca A Dagg; Sarah-Jane Schramm; Antonia Pritchard; Ken Dutton-Regester; Felicity Newell; Anna Fitzgerald; Catherine A Shang; Sean M Grimmond; Hilda A Pickett; Jean Y Yang; Jonathan R Stretch; Andreas Behren; Richard F Kefford; Peter Hersey; Georgina V Long; Jonathan Cebon; Mark Shackleton; Andrew J Spillane; Robyn P M Saw; Núria López-Bigas; John V Pearson; John F Thompson; Richard A Scolyer; Graham J Mann
Journal:  Nature       Date:  2017-05-03       Impact factor: 49.962

Review 10.  Genetics of metastasis: melanoma and other cancers.

Authors:  Noel Turner; Olivia Ware; Marcus Bosenberg
Journal:  Clin Exp Metastasis       Date:  2018-05-02       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.